GlassScriptPhysician profile
Anil K Pahuja
NPI 1568781573
$6,649.55
in general payments reported to CMS, 2019-2025
25 companies · $575 in 2025
The $575 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,572 · 2020: $290 · 2021: $728 · 2022: $401 · 2023: $848 · 2024: $1,236 · 2025: $575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,836 · Travel and Lodging: $807 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,836.21 |
| Travel and Lodging | $807.03 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,635.65 | 2019 | |
| Intuitive Surgical, INC. | $1,412.88 | 2023-2024 | Da Vinci Surgical System |
| Ethicon US, LLC | $877.58 | 2019-2020 | |
| Kerecis Limited | $581.76 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Davol INC. | $376.51 | 2020-2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $352.86 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Allergan, INC. | $218.82 | 2019-2022 | |
| Becton, Dickinson and Company | $182.84 | 2022-2024 | Phasix Mesh |
| Novo Nordisk INC | $177.42 | 2021-2022 | |
| Smith+Nephew, INC. | $126.87 | 2019-2021 | |
| Abbvie INC. | $109.84 | 2023-2025 | |
| Innovation Technologies INC | $107.01 | 2021 | |
| Medtronic, INC. | $99.04 | 2022-2024 | Endoflip |
| Sanara Medtech INC. | $92.37 | 2024 | Celleraterx |
| Misonix INC | $74.90 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $52.63 | 2021 | |
| Conmed Corporation | $44.53 | 2025 | Airseal |
| Next Science LLC | $19.90 | 2019 | |
| Solventum Corporation | $18.68 | 2024 | V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Teleflex LLC | $16.35 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.41 | 2023 | Seglentis |
| Lilly USA, LLC | $14.21 | 2024 | Zepbound |
| Endo Pharmaceuticals INC. | $14.17 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.85 | 2019 | |
| Intra-Sana Laboratories | $13.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Pahuja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.